Sex and gender influences on pharmacological response: an overview. - Wikidata - awgldk - TriplyDB

Sex and gender influences on pharmacological response: an overview.

Sex and gender influences on pharmacological response: an overview.

http://www.wikidata.org/entity/Q38214338

about

Sex and gender considerations in Canadian clinical practice guidelines: a systematic review Essential metrics for assessing sex & gender integration in health research proposals involving human participants.Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes.Sex-Divergent Clinical Outcomes and Precision Medicine: An Important New Role for Institutional Review Boards and Research Ethics Committees.Androgen-mediated sex bias impairs efficiency of leukotriene biosynthesis inhibitors in males.Sex and gender considerations in transplantation research: protocol for a scoping review.Differences in drug use between men and women: an Italian cross sectional study.From sexless to sexy: Why it is time for human genetics to consider and report analyses of sex.Pharmacokinetic Properties and Human Use Characteristics of an FDA-Approved Intranasal Naloxone Product for the Treatment of Opioid Overdose.Sex differences in substance use disorders: focus on side effects.Sex, drugs, and heart failure: a sex-sensitive review of the evidence base behind current heart failure clinical guidelines

P2860

Q37735894-918FD095-38E8-4D48-BB30-4DC9F4B00339 Q38602212-D2495501-1587-4D68-9084-17DA9045EFA7 Q38623577-9102D615-C27E-4600-86E5-3DE28C9D28CE Q38635940-D23FE894-427E-4E76-B2F6-19B95D46C8A7 Q38665189-EF56DA2D-0A6F-4388-A866-FD20BDDC954B Q40050463-051FAF68-76AD-44D7-898C-EED1FF9CF909 Q41609725-7AA98825-9B88-4AA2-A0E2-D82DBDB54FD1 Q42355531-849CA136-B084-47E2-845E-1A243ED84760 Q44336921-121A5989-0C3D-451F-9478-E9B6D5F175C0 Q48819937-7F277B96-E0DA-46EA-8D7B-75AFFB4DD8F2 Q57137897-BCA21D39-BEC9-408A-90C0-8E94447F525B

P2860

Sex and gender influences on pharmacological response: an overview.

http://www.wikidata.org/entity/Q38214338

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Sex and gender influences on pharmacological response: an overview.

@en

type

label

Sex and gender influences on pharmacological response: an overview.

@en

prefLabel

Sex and gender influences on pharmacological response: an overview.

@en

P1433

Q38214338-29DCBCCE-DA55-498C-BB72-A18E23A24C07

P1476

Q38214338-F8A5F97B-0907-4344-A5BA-C0F73AD846FD

P2093

Q38214338-2CFD40F3-53A4-49FB-9AC4-56E112974D63

Q38214338-37C364FD-F8A8-4CAB-BF0D-EB19D8228667

P2860

Q38214338-0059AF21-EF1E-4FD5-91AD-943F3FB4E3D6

Q38214338-009C65AB-C188-4D80-ADCE-8C4C37542320

Q38214338-01E9FC18-8C16-4BFC-995D-67FEA0172C2E

Q38214338-02084FDD-2A6D-476D-A913-96B929CFBFDE

Q38214338-0290B3E9-20D9-4434-8DD5-F6F1C914EB73

Q38214338-02B42474-BEB3-4C7D-93DC-D7FEF61F3608

Q38214338-04F5965E-4FF0-4740-AC12-AAFE6C98A244

Q38214338-0627FB5D-8EE9-42CB-8B23-598DA84F425B

Q38214338-07052D79-7159-4E24-8131-001EF46A338A

Q38214338-07AF48ED-A39D-41A0-93E8-56C1201AEDC9

P304

Q38214338-44737CC9-43E4-42B9-BFC9-79B9462C98F9

P31

Q38214338-8569B86F-673D-4A80-9609-E24329EB8451

P356

Q38214338-935F856B-167F-41E6-9E89-B5E597202447

P407

Q38214338-C13A47BB-8C6D-478C-8A91-716253C647E8

P433

Q38214338-23D6AD98-93CE-426B-85FE-6D9DA7E2CA99

P478

Q38214338-763B5309-21B4-49E0-A5EF-DDFDCF8833F0

P577

Q38214338-CA55C8C9-304F-41DE-96A7-4789A63D7885

P5875

Q38214338-817CA33A-4A5F-4B5E-81F8-6B6CCD521E17

P698

Q38214338-F39E479B-F079-49CF-95B2-DE4DFFDE2FD8

P921

Q38214338-2E49AB83-6EA6-4053-A945-8F1980919E82

P356

17512433.2014.922866

P1433

Expert Review of Clinical Pharmacology

P1476

Sex and gender influences on pharmacological response: an overview.

@en

P2093

Flavia Franconi

http://www.w3.org/2001/XMLSchema#string

Ilaria Campesi

http://www.w3.org/2001/XMLSchema#string

P2860

Incidence of lactic acidosis in metformin users

Non-nucleoside reverse transcriptase inhibitors: a review on pharmacokinetics, pharmacodynamics, safety and tolerability

Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients

Age and sex differences in the treatment of patients with initial acute myocardial infarction: a community-wide perspective

Sex disparities in treatment of cardiac risk factors in patients with type 2 diabetes

Drug interactions with smoking

Gender and health: an update on hypotheses and evidence

Do gender and race affect decisions about pain management?

AMP-activated protein kinase induces a p53-dependent metabolic checkpoint

Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy

P304

469-485

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/17512433.2014.922866

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2014-05-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262609556

http://www.w3.org/2001/XMLSchema#string

P698

24857340

http://www.w3.org/2001/XMLSchema#string

P921